关于CRISPR-Cas12a基因组编辑人类多能干细胞和功能β类细胞生成中的蛋白氨酸酸酶的协议
Javier Negueruela1, Valerie Vandenbempt1, Stephanie Talamantes1
1Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium.
STAR protocols
|September 7, 2024
概括
这项研究详细介绍了用于治疗代谢疾病的人类干细胞的CRISPR-Cas12a基因编辑协议. 编辑的细胞分化为胰腺细胞,并在体内成熟,提供了一种新的基因治疗方法.
科学领域:
- 生物技术是生物技术.
- 干细胞生物学 干细胞生物学
- 基因治疗 基因治疗
背景情况:
- 代谢性疾病对健康构成重大挑战.
- 人类多能干细胞为再生医学提供了一个多功能平台.
- 针对性基因编辑对开发新型治疗策略具有前景.
研究的目的:
- 在人类胚胎干细胞中建立CRISPR-Cas12a介导的蛋白质氨酸酸酶基因淘汰的协议.
- 为了将编辑的干细胞分化为功能性胰腺小岛样细胞.
- 在小鼠模型中评估这些细胞的体内成熟.
主要方法:
- 基因编辑CRISPR-Cas12a被用来敲除人类胚胎干细胞中的特定基因.
- 标准差异化协议被用于生成胰腺小岛状球形.
- 在小鼠的囊下植入了球体,用于体内成熟和评估.
主要成果:
- 成功生成基因编辑的人类胚胎干细胞克隆.
- 编辑的细胞在胰腺球体内分化为β类细胞.
- 证明工程球体的体内成熟潜力.
结论:
- 提出的协议使人类干细胞中精确的基因编辑成为潜在的代谢性疾病疗法.
- 工程化胰腺细胞显示出移植和体内功能成熟的前景.
- 这种方法促进了利用干细胞技术开发向基因疗法的发展.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


